HTG Molecular Diagnostics to Present Corporate Overview at Fall Investor Conferences

TUCSON, Ariz. , Sept. 08, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced John Lubniewski, President and CEO of HTG, will present virtually at the H.C.